| Jul 22 |
Ionis plots next steps for Angelman drug Biogen passed on
|
| Jul 22 |
Sage Therapeutics/Biogen’s episodic therapy zuranolone could change MDD treatment
|
| Jul 19 |
Ionis (IONS) Completes Enrolment for Rare Disease Drug Study
|
| Jul 17 |
Why Biogen Inc. (BIIB) is a Top Value Stock for the Long-Term
|
| Jul 16 |
Three Surprising Names That Could Be On Biogen's Buyout Shortlist
|
| Jul 16 |
Viridian, Pharvaris said to be among prime M&A targets for Biogen
|
| Jul 16 |
Bernie Sanders: 'Getting Sick In America Should Not Mean Going Bankrupt, Losing Your Home, Car, Or Life Savings'
|
| Jul 13 |
Morgan Stanley sees $180B patent cliff, $380B deal capacity fueling biopharma M&A
|
| Jul 13 |
Biogen's Diverse Drug Portfolio Faces Competitive Challenges In 2024
|
| Jul 11 |
Biogen Stock: Cheapish, But With Few Growth Prospects
|
